Codexis (CDXS) Deferred Taxes (2014 - 2017)

Codexis (CDXS) recorded quarterly Deferred Taxes of $52000.0 in Q3 2017, down 80.23% quarter-over-quarter from $263000.0 in Q3 2015.

Codexis (CDXS) Deferred Taxes (2014 - 2017) Analysis & Trends

Codexis' Deferred Taxes history runs 3 years deep, the most recent figure standing at $52000.0 for Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -859,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -65.30 Mn
9 Abivax 94.37 Bn 94.37 Bn - -
10 Codexis 236.00 Mn 170.86 Mn 13.18 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2017 52,000.00
Sep 30, 2015 263,000.00
Sep 30, 2014 160,000.00